It is demonstrated that silymarin and silybin improve neurogenesis in the prefrontal cortex and hippocampus by modulating SOD and catalase (CAT) activities, alleviating symptoms of depression and anxiety (Rostamian et al., 2023). This evidence concerns the gene SOD1 and depressive symptom measurement.